BridgeBio Oncology Therapeutics, Inc. — All Filings
135 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
3
4
424B3
424B4
425
8-A12B
8-K
CERT
CORRESP
DRS
DRS/A
DRSLTR
EFFECT
POS AM
S-1
S-1/A
S-1MEF
S-4
S-4/A
S-8
SC 13D
SC 13G
SCHEDULE 13D
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 8-K | CURRENT REPORT | 0001213900-25-075190 | Aug 13, 2025 | Aug 11, 2025 |
| 3 | — | 0001213900-25-074387 | Aug 11, 2025 | — |
| 4 | — | 0001213900-25-074383 | Aug 11, 2025 | — |
| 4 | — | 0001213900-25-074379 | Aug 11, 2025 | — |
| 4 | — | 0001213900-25-074375 | Aug 11, 2025 | — |
| 4 | — | 0001213900-25-074368 | Aug 11, 2025 | — |
| 4 | — | 0001213900-25-074364 | Aug 11, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-072312 | Aug 6, 2025 | — |
| 425 | CURRENT REPORT | 0001213900-25-071396 | Aug 4, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-071392 | Aug 4, 2025 | — |
| 10-Q | QUARTERLY REPORT | 0001213900-25-070659 | Aug 1, 2025 | Jun 30, 2025 |
| SCHEDULE 13G/A | — | 0001104659-25-072172 | Jul 30, 2025 | — |
| SCHEDULE 13G | — | 0000950170-25-098552 | Jul 24, 2025 | — |
| 424B3 | PROSPECTUS SUPPLEMENT | 0001213900-25-066296 | Jul 22, 2025 | — |
| 425 | FORM 425 | 0001213900-25-065883 | Jul 21, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-062955 | Jul 11, 2025 | — |
| 425 | CURRENT REPORT | 0001213900-25-062956 | Jul 11, 2025 | — |
| 424B4 | PROSPECTUS | 0001213900-25-062864 | Jul 10, 2025 | — |
| EFFECT | — | 9999999995-25-002217 | Jul 10, 2025 | — |
| CORRESP | — | 0001213900-25-062226 | Jul 9, 2025 | — |
| S-4/A | REGISTRATION STATEMENT | 0001213900-25-062224 | Jul 9, 2025 | — |
| CORRESP | — | 0001213900-25-060460 | Jul 1, 2025 | — |
| S-4/A | REGISTRATION STATEMENT | 0001213900-25-060456 | Jul 1, 2025 | — |
| UPLOAD | — | 0000000000-25-006779 | Jun 27, 2025 | — |
| CORRESP | — | 0001213900-25-056324 | Jun 20, 2025 | — |
| S-4 | REGISTRATION STATEMENT | 0001213900-25-056321 | Jun 20, 2025 | — |
| UPLOAD | — | 0000000000-25-006146 | Jun 11, 2025 | — |
| DRSLTR | — | 0001213900-25-049565 | May 30, 2025 | — |
| DRS/A | — | 0001213900-25-049554 | May 30, 2025 | — |
| 10-Q | QUARTERLY REPORT | 0001213900-25-044424 | May 15, 2025 | Mar 31, 2025 |
| UPLOAD | — | 0000000000-25-005054 | May 13, 2025 | — |
| SCHEDULE 13G/A | — | 0002052113-25-000396 | Apr 22, 2025 | — |
| DRS | — | 0001213900-25-031720 | Apr 15, 2025 | — |
| SCHEDULE 13G | — | 0002052113-25-000302 | Apr 15, 2025 | — |
| DRSLTR | — | 0001213900-25-031721 | Apr 14, 2025 | — |
| 10-K | ANNUAL REPORT | 0001213900-25-022387 | Mar 11, 2025 | Dec 31, 2024 |
| 425 | FORM 425 | 0001213900-25-021210 | Mar 6, 2025 | — |
| SCHEDULE 13D/A | — | 0001213900-25-020316 | Mar 4, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-018997 | Mar 3, 2025 | Feb 28, 2025 |
| 425 | CURRENT REPORT | 0001213900-25-018999 | Mar 3, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-018334 | Feb 28, 2025 | — |
| 425 | CURRENT REPORT | 0001213900-25-018335 | Feb 28, 2025 | — |
| 3 | — | 0001213900-25-012280 | Feb 11, 2025 | Feb 8, 2025 |
| 4 | — | 0001213900-25-011813 | Feb 10, 2025 | Feb 8, 2025 |
| 4 | — | 0001213900-25-011810 | Feb 10, 2025 | Feb 8, 2025 |
| 8-K | CURRENT REPORT | 0001213900-25-011454 | Feb 10, 2025 | Feb 8, 2025 |
| 10-Q | QUARTERLY REPORT | 0001213900-24-098483 | Nov 14, 2024 | Sep 30, 2024 |
| SC 13G | — | 0000080255-24-001487 | Nov 14, 2024 | — |
| SC 13G | — | 0002012383-24-003714 | Nov 8, 2024 | — |
| SC 13G | — | 0002012383-24-001286 | Oct 22, 2024 | — |